Lupus & antiphospholipid syndrome

Employment Trajectories of Patients With Systemic Lupus Erythematosus and Factors Driving Transitions Between States

Arthritis Care Res (Hoboken)Published Retrospective cohort study

Authors' conclusion

There is a lack of transitions between employment categories over the disease course, high persistence in the disability benefits, and economically inactive categories and a low probability of reentry after leaving the workforce. Neuropsychiatric and renal damage are key drivers of disability.

Study context

Population
Patients with systemic lupus erythematosus (SLE), single centre1,155 ever employed
Participants
1,806 patients
Outcome
Final employment status (employed, unemployed, disability benefit, retired, economically inactive, death while employed) and transitions between employment states
Methodological detailssingle-centre, multinomial logistic regression, Sankey diagrams
  • Single-centre
  • Multinomial logistic regression
  • Sankey diagrams

Main finding

As reported in the abstract

Permanent transition out of employment among ever employed

Permanently transitioned out of employment (of 1,155 ever employed)

398

34.5%

To disability benefits

82

To short-term sick leave

71

Observational data: associations, not effects.

Further findings

Disability benefit category: disease burden

Highest severe flare rate
0.3/year
GC use >30 mg/day
47.8%
High retention; substantial proportion died during follow-up

Damage domains associated with early retirement

Malignancy damage, OR
2.51
Endocrine damage, OR
2.56
Musculoskeletal damage, OR
1.47

Damage domains associated with disability

Neuropsychiatric damage, OR
1.87
Renal damage, OR
1.89
Similar patterns to early retirement

Original publication

Employment Trajectories of Patients With Systemic Lupus Erythematosus and Factors Driving Transitions Between States. Arthritis Care Res (Hoboken). Published 27 July 2026. doi:10.1002/acr.80123

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.